Cell BiologybioRxivPreprint
High-content screening identifies FDA-approved activators of mitophagy
Carlo Viscomi, Giacomo Giacchin, Valeria Balmaceda…·Cristiane Benincá
The paper screens FDA-approved compounds to find mitophagy activators, identifying Meptazinol and Ponatinib as top candidates that increase mitolysosomes but do not rescue bioenergetic defects in mitochondrial diseases.
DOI 10.64898/2026.11.06.764995